Cargando…
Zwitterionic rhodamine-CPT prodrug nanoparticles with GSH/H(2)O(2) responsiveness for cancer theranostics
Rationale: Fluorescently traceable prodrugs, which can monitor their biodistribution in vivo and track the kinetics of drug delivery in living cells, are promising for constructing theranostic medicines. However, due to their charge and hydrophobicity, most of the fluorescently traceable prodrugs ex...
Autores principales: | Mu, Xueluer, Huang, Zejian, Feng, Wenbi, Zhai, Manyu, Wang, Yukun, Zhou, Dan, Zhou, Xianfeng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9800722/ https://www.ncbi.nlm.nih.gov/pubmed/36593965 http://dx.doi.org/10.7150/thno.78884 |
Ejemplares similares
-
GSH-sensitive Pt(IV) prodrug-loaded phase-transitional nanoparticles with a hybrid lipid-polymer shell for precise theranostics against ovarian cancer
por: Huang, Hui, et al.
Publicado: (2019) -
Multimodal imaging and photothermal/chemodynamic therapy of cervical cancer using GSH-responsive MoS(2)@MnO(2) theranostic nanoparticles
por: Shao, Runrun, et al.
Publicado: (2023) -
Orally Bioavailable
Prodrugs of ψ-GSH:
A Potential Treatment for Alzheimer’s Disease
por: Xie, Wei, et al.
Publicado: (2022) -
An inorganic prodrug, tellurium nanowires with enhanced ROS generation and GSH depletion for selective cancer therapy
por: Wu, Ying, et al.
Publicado: (2019) -
The Alleviation of LPS-Induced Murine Acute Lung Injury by GSH-Mediated PEGylated Artesunate Prodrugs
por: Hao, Dan-Li, et al.
Publicado: (2022)